About this FactMed analysis covering adverse side effect reports of ALBUMINAR-25 patients who developed HEADACHE.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking ALBUMINAR-25 reported HEADACHE to the FDA. A total of 49 ALBUMINAR-25 drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALBUMINAR-25 and HEADACHE. In doing so, we compare ALBUMINAR-25 with other drugs that cause HEADACHE, to help you evaluate whether or not ALBUMINAR-25 causes HEADACHE. Likewise, this page shows the most highly-reported side effects of ALBUMINAR-25, so you can see if HEADACHE ranks among ALBUMINAR-25's most well-known side effects.
Summary Statistics
Reports of ALBUMINAR-25 causing HEADACHE: 2
Reports of any side effect of ALBUMINAR-25 : 49
Percentage of ALBUMINAR-25 patients where HEADACHE is a reported side effect: 4.0816%

FDA reports of any drug causing HEADACHE : 141115
Average percentage for all medicated patients where HEADACHE is reported as a complication: 0.8844%

Physician opinion on ALBUMINAR-25 as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALBUMINAR-25:
PRODUCT USED FOR UNKNOWN INDICATION ( 9 patients )
HYPOALBUMINAEMIA ( 6 patients )
CARDIAC FAILURE ( 2 patients )
SURGERY ( 2 patients )
DRUG USE FOR UNKNOWN INDICATION ( 2 patients )
HAEMODYNAMIC INSTABILITY ( 2 patients )
METASTASES TO LYMPH NODES ( 2 patients )
NEPHROTIC SYNDROME ( 2 patients )
RENAL FAILURE ACUTE ( 2 patients )
URINE OUTPUT DECREASED ( 2 patients )
HEPATIC CIRRHOSIS ( 2 patients )
HYPOTENSION ( 2 patients )
MYASTHENIA GRAVIS ( 1 patients )
PLASMAPHERESIS ( 1 patients )
LIVER DISORDER ( 1 patients )
PNEUMONIA ( 1 patients )
ASCITES ( 1 patients )
CENTRAL VENOUS PRESSURE DECREASED ( 1 patients )
GENERALISED OEDEMA ( 1 patients )
LYMPHANGIOMA ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HEADACHE:

ASPIRIN (8010 patients)
VIOXX (7647 patients)
TYSABRI (7046 patients)
ENBREL (6413 patients)
HUMIRA (6344 patients)
FOSAMAX (6320 patients)
SEROQUEL (4755 patients)
AVONEX (4430 patients)
CHANTIX (4352 patients)
LIPITOR (4317 patients)
SYNTHROID (4182 patients)
NEXIUM (4118 patients)
PREDNISONE (3832 patients)
METHOTREXATE (3717 patients)
FORTEO (3668 patients)
LISINOPRIL (3370 patients)
REMICADE (3344 patients)
LYRICA (3308 patients)
XANAX (3307 patients)
CYMBALTA (3244 patients)
NEURONTIN (3049 patients)
ACCUTANE (3042 patients)
ZOLOFT (3034 patients)
HEPARIN SODIUM INJECTION (3020 patients)
PAXIL (3012 patients)
FOLIC ACID (2700 patients)
SOLIRIS (2684 patients)
ATENOLOL (2625 patients)
OMEPRAZOLE (2564 patients)
ACETAMINOPHEN (2562 patients)
AMBIEN (2538 patients)
BYETTA (2501 patients)
PRILOSEC (2483 patients)
COUMADIN (2464 patients)
HYDROCHLOROTHIAZIDE (2423 patients)
SIMVASTATIN (2394 patients)
IBUPROFEN (2388 patients)
VITAMIN D (2333 patients)
LEVOTHYROXINE SODIUM (2313 patients)
CELEBREX (2294 patients)
LASIX (2287 patients)
ALBUTEROL (2287 patients)
CRESTOR (2259 patients)
ZOMETA (2258 patients)
LEXAPRO (2228 patients)
TOPROL-XL (2180 patients)
METFORMIN HCL (2128 patients)
PLAVIX (2072 patients)
NORVASC (2061 patients)
SANDOSTATIN LAR (2022 patients)
REBIF (1999 patients)
OXYCONTIN (1990 patients)
PROTONIX (1945 patients)
VICODIN (1924 patients)
PREVACID (1917 patients)
ZOCOR (1881 patients)
ALEVE (CAPLET) (1871 patients)
DIOVAN (1845 patients)
CLONAZEPAM (1843 patients)
ATIVAN (1837 patients)
CALCIUM (1834 patients)
EFFEXOR (1825 patients)
GABAPENTIN (1817 patients)
SINGULAIR (1793 patients)
PREMARIN (1755 patients)
FUROSEMIDE (1748 patients)
LORAZEPAM (1716 patients)
ADVAIR DISKUS 100/50 (1707 patients)
KLONOPIN (1699 patients)
PROZAC (1682 patients)
WELLBUTRIN (1653 patients)
PERCOCET (1622 patients)
NIASPAN (1607 patients)
EFFEXOR XR (1546 patients)
AREDIA (1509 patients)
TOPAMAX (1500 patients)
PREDNISONE TAB (1487 patients)
MIRENA (1450 patients)
LAMICTAL (1444 patients)
DURAGESIC-100 (1428 patients)
PREDNISOLONE (1427 patients)
PEGASYS (1417 patients)
POTASSIUM CHLORIDE (1394 patients)
PRISTIQ (1377 patients)
VALIUM (1376 patients)
YAZ (1340 patients)
LEVAQUIN (1333 patients)
ALPRAZOLAM (1322 patients)
DIGOXIN (1320 patients)
LANTUS (1318 patients)
ZYRTEC (1316 patients)
MULTI-VITAMIN (1309 patients)
CELEXA (1296 patients)
MULTI-VITAMINS (1283 patients)
LORTAB (1273 patients)
SPIRIVA (1246 patients)
BENADRYL (1242 patients)
YASMIN (1242 patients)
TRAZODONE HCL (1239 patients)
RIBAVIRIN (1216 patients)
TRAMADOL HCL (1213 patients)
GILENYA (1201 patients)
DEXAMETHASONE (1200 patients)
ZOFRAN (1176 patients)
DIAZEPAM (1172 patients)
METOPROLOL TARTRATE (1157 patients)
WARFARIN SODIUM (1133 patients)
OXYCODONE HCL (1127 patients)
AMLODIPINE (1117 patients)
TYLENOL (CAPLET) (1063 patients)
GLUCOPHAGE (1063 patients)
FLEXERIL (1058 patients)
VIAGRA (1056 patients)
TYLENOL (1047 patients)
ALLOPURINOL (1033 patients)
BETASERON (1032 patients)
DECADRON (1031 patients)
BACLOFEN (1027 patients)
FLONASE (1018 patients)
ALLEGRA (1017 patients)
INSULIN (1013 patients)
XOLAIR (1000 patients)
AMITRIPTYLINE HCL (995 patients)
ZANTAC (993 patients)
PRADAXA (989 patients)
FISH OIL (986 patients)
DEPAKOTE (976 patients)
ASCORBIC ACID (974 patients)
NUVARING (971 patients)
ZYPREXA (966 patients)
ALLI (964 patients)
MORPHINE (958 patients)
AMOXICILLIN (958 patients)
CLONIDINE (953 patients)
VITAMIN B-12 (911 patients)
STRATTERA (906 patients)
NITROGLYCERIN (888 patients)
COREG (887 patients)
CIALIS (886 patients)
VITAMIN E (883 patients)
BONIVA (879 patients)
COZAAR (877 patients)
RECLAST (874 patients)
IMITREX (868 patients)
LEVITRA (864 patients)
ACTOS (864 patients)
RISPERDAL (863 patients)
VALTREX (861 patients)
ZETIA (858 patients)
ACTONEL (855 patients)
METOPROLOL (850 patients)
LEVOXYL (849 patients)
MOTRIN (848 patients)
AVANDIA (840 patients)
CITALOPRAM HYDROBROMIDE (836 patients)
METFORMIN (833 patients)
TEGRETOL (832 patients)
PAROXETINE HCL (824 patients)
RANITIDINE (819 patients)
LUNESTA (812 patients)
NAPROXEN (809 patients)
CLARITIN (802 patients)
ORTHO EVRA (792 patients)
EXJADE (789 patients)
JANUVIA (788 patients)
ZITHROMAX (775 patients)
KEPPRA (774 patients)
ULTRAM (773 patients)
SPIRONOLACTONE (768 patients)
GLIPIZIDE (763 patients)
AVELOX (757 patients)
PEG-INTRON (748 patients)
FENTANYL (748 patients)
SYMBICORT (740 patients)
SOMA (739 patients)
GLYBURIDE (735 patients)
VITAMINS (723 patients)
REGLAN (723 patients)
ELAVIL (719 patients)
ALENDRONATE SODIUM (714 patients)
ALTACE (714 patients)
ABILIFY (708 patients)
CALCIUM CARBONATE (702 patients)
ACIPHEX (701 patients)
CYCLOPHOSPHAMIDE (698 patients)
LANSOPRAZOLE (696 patients)
ARIMIDEX (696 patients)
ALEVE (696 patients)
HYDROCODONE BITARTRATE (695 patients)
SIMCOR (691 patients)
HYDROCODONE (688 patients)
VERAPAMIL (682 patients)
BENICAR (680 patients)
PEPCID (673 patients)
CIPROFLOXACIN (667 patients)
LOVENOX (663 patients)
IRON (662 patients)
HUMALOG (660 patients)
WELLBUTRIN XL (659 patients)
PLAQUENIL (653 patients)
DILANTIN (653 patients)
FLOMAX (652 patients)
DILAUDID (650 patients)
BACTRIM (648 patients)
VICTOZA (648 patients)
GAMMAGARD LIQUID (647 patients)
BEXTRA (642 patients)
COPEGUS (637 patients)
ACYCLOVIR (634 patients)
PROMETHAZINE (632 patients)
Most common side effects for patients taking ALBUMINAR-25:
BLOOD PRESSURE DECREASED (11 patients)
INFUSION RELATED REACTION (7 patients)
HEPATITIS C POSITIVE (4 patients)
OXYGEN SATURATION DECREASED (4 patients)
HEPATIC FAILURE (3 patients)
HEPATITIS C ANTIBODY POSITIVE (3 patients)
TACHYCARDIA (3 patients)
HEPATITIS C VIRUS TEST POSITIVE (3 patients)
ANTINUCLEAR ANTIBODY POSITIVE (3 patients)
PYREXIA (3 patients)
HYPERSENSITIVITY (3 patients)
CHILLS (3 patients)
BLOOD CULTURE POSITIVE (2 patients)
PLATELET COUNT DECREASED (2 patients)
LOSS OF CONSCIOUSNESS (2 patients)
PRODUCT QUALITY ISSUE (2 patients)
KLEBSIELLA INFECTION (2 patients)
BACTERIAL INFECTION (2 patients)
BODY TEMPERATURE INCREASED (2 patients)
HYPOXIA (2 patients)
HYPOTENSION (2 patients)
PRURITUS (2 patients)
PULMONARY EMBOLISM (2 patients)
RASH (2 patients)
HEPATITIS C RNA POSITIVE (2 patients)
CROHN'S DISEASE (2 patients)
RESTLESSNESS (2 patients)
TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT (2 patients)
HEPATITIS B VIRUS TEST POSITIVE (2 patients)
HEPATITIS B POSITIVE (2 patients)
DYSKINESIA (2 patients)
HEPATITIS (2 patients)
HEPATITIS C (2 patients)
HEADACHE (2 patients)
FOAMING AT MOUTH (2 patients)
FLUSHING (2 patients)
FATIGUE (1 patients)
HAEMOGLOBIN DECREASED (1 patients)
HAEMOLYSIS (1 patients)
EYE SWELLING (1 patients)
ENTEROCOLONIC FISTULA (1 patients)
HEPATIC FUNCTION ABNORMAL (1 patients)
DYSPNOEA (1 patients)
HEPATITIS B CORE ANTIGEN POSITIVE (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
HEPATITIS B SURFACE ANTIGEN POSITIVE (1 patients)
DIARRHOEA (1 patients)
ABDOMINAL DISCOMFORT (1 patients)
CYANOSIS (1 patients)
CULTURE URINE POSITIVE (1 patients)
CORONARY ARTERY INSUFFICIENCY (1 patients)
COOMBS DIRECT TEST POSITIVE (1 patients)
COMPLICATIONS OF TRANSPLANTED LIVER (1 patients)
CATHETER SITE HAEMORRHAGE (1 patients)
CARDIO-RESPIRATORY ARREST (1 patients)
BLOOD PRESSURE SYSTOLIC DECREASED (1 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (1 patients)
BLOOD PRESSURE FLUCTUATION (1 patients)
LABORATORY TEST ABNORMAL (1 patients)
LARGE INTESTINE PERFORATION (1 patients)
LIP SWELLING (1 patients)
LIVER TRANSPLANT (1 patients)
BLOOD GLUCOSE INCREASED (1 patients)
NEUTROPHIL COUNT DECREASED (1 patients)
NOSOCOMIAL INFECTION (1 patients)
ORTHOPNOEA (1 patients)
BLOOD FIBRINOGEN DECREASED (1 patients)
PALLOR (1 patients)
BLOOD CREATININE INCREASED (1 patients)
PNEUMONIA KLEBSIELLA (1 patients)
POST PROCEDURAL COMPLICATION (1 patients)
PRODUCT OUTER PACKAGING ISSUE (1 patients)
PRODUCT PACKAGING QUANTITY ISSUE (1 patients)
BLOOD BILIRUBIN INCREASED (1 patients)
PROTHROMBIN TIME PROLONGED (1 patients)
BACK PAIN (1 patients)
ASTHENIA (1 patients)
PULMONARY OEDEMA (1 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (1 patients)
ANAPHYLACTIC SHOCK (1 patients)
RECTAL HAEMORRHAGE (1 patients)
RENAL DISORDER (1 patients)
ANAPHYLACTIC REACTION (1 patients)
RETROPERITONEAL ABSCESS (1 patients)
SEROLOGY POSITIVE (1 patients)
SWELLING FACE (1 patients)
ALANINE AMINOTRANSFERASE INCREASED (1 patients)
ADVERSE EVENT (1 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (1 patients)
URINARY TRACT INFECTION FUNGAL (1 patients)
URINE OUTPUT DECREASED (1 patients)
URTICARIA (1 patients)
VENA CAVA THROMBOSIS (1 patients)
WHITE BLOOD CELL COUNT DECREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALBUMINAR-25


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HEADACHE and ALBUMINAR-25, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALBUMINAR-25, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALBUMINAR-25. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALBUMINAR-25 experts. If you are a healthcare provider experienced in prescribing ALBUMINAR-25, please register here.
giCould not connect: